11/16/16
The Walter Reed Army Institute of Research aims to enroll 75 people aged 18 to 49 to test the safety and efficacy of the experimental Zika Purified Inactivated Virus vaccine ( ZPIV ). The director of the National Institute of Allergy and Infectious Disease, Anthony S. Fauci, MD shares some insights on the effort in this Healio announcement.